Top Markets
Coin of the day
Histogen Inc. Histogen Inc.

Histogen Inc.

HSTO
Classifica tra le azioni #40868
Histogen Inc. operates as a clinical-stage biotechnology company, focusing on... Histogen Inc. operates as a clinical-stage biotechnology company, focusing on the development of novel, stem cell-free biologic products derived from its proprietary hypoxia-generated growth factor technology platform. Among its offerings is HST-003, a human extracellular matrix, currently undergoing Phase 1/2 clinical trials to mend articular cartilage defects in the knee. Additionally, the company is advancing HST-004, a cell-conditioned media solution designed for spinal disc repair, and Emricasan, an orally active pan-caspase inhibitor targeting COVID-19 treatment. In its preclinical pipeline, Histogen is developing CTS-2090 and CTS-2096. These are selective caspase-1 inhibitors formulated to suppress inflammasome activation and intervene in a range of inflammation-mediated conditions. Founded in 2007, Histogen Inc. maintains its headquarters in San Diego, California.
Prezzo delle azioni
$0.02765
Ultima sincronizzazione: 2024-12-23
Capitalizzazione di mercato
$69.04K
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia Histogen Inc. (HSTO)

Categoria

Cronologia dei frazionamenti azionari per Histogen Inc. (HSTO)
L’azione Histogen Inc. (simbolo: HSTO) ha subito un totale di 2 frazionamenti.
L’ultimo frazionamento è avvenuto il Jun 03, 2022.
Una quota di HSTO acquistata prima di May 27, 2020 equivale oggi a 0.005 quote di HSTO.
Elenco dei frazionamenti azionari
Anno Frazionamento Moltiplicatore Moltiplicatore cumulativo
2022-06-03 1:20 x0.05 x0.005
2020-05-27 1:10 x0.1 x0.1
Frazionamenti azionari di aziende simili o concorrenti
Azienda Numero di frazionamenti azionari Moltiplicatore cumulativo Il paese
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE